Speak directly to the analyst to clarify any post sales queries you may have.
The study considers a detailed scenario of the present syringes & needles market and its market dynamics for 2023−2028 in Europe. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
KEY HIGHLIGHTS
- In 2022, Europe Syringes and Needles market was valued at $7.97 billion and is expected to grow at a CAGR of 6.70% during the forecast period considering the facts that Europe is the growing market for Syringes and Needles products after the US on a global scale.
- The demand for Syringes and Needles market is rising due to multiple factors, including an increasing geriatric population, growing consumer awareness regarding usage, high prevalence of chronic cases, and increasing adoption of Syringes and Needles in treating diabetes.
- Other factors such as technological & material advancements, introduction of new products, well-developed healthcare infrastructure, extensive research & development activities, presence of leading key vendors, and government support also contribute to the overall Syringes and Needles market growth.
- By Product type, Syringes accounted for the highest share of 62.10% in 2022 and is projected to grow at the highest CAGR of 7.48% during the forecast period. This is mainly due to the increase in the recommendation and use of syringes by physicians/clinicians and people across Europe.
- By patient type, the adult segment accounted for the highest share of 69.44% in 2022 and is projected to grow at the highest CAGR of 6.99% during the forecast period. This increase is mainly attributed to the increasing number of chronic diseases among the adult population, such as diabetes.
- In End-User type, Hospitals segment accounted for the highest share of 56.95% in 2022 and is projected to grow at the highest CAGR of 7.39% during the forecast period. This is due to the increase in the number of surgeries performed in hospitals across Europe.
- BD, CardinalHealth, B Braun, Nipro, and Terumo Corp are some of the leading players currently dominating the Europe syringes & needles market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the syringes & needles market and gain access to commercially launched products.
VENDORS LIST
- BD
- Braun
- ICU Medical
- Nipro Medical
- Terumo
- Baxter
- Numedico Technologies
- Codan
- DeRoyal
- Gerresheimer
- Henke Sass Wolf
- HTL Strefa
- Medtronic
- Med XL
- ATS Life Sciences
- Owen Mumford
- PentaFerte
- Schott
- Metier Medical
- CardinalHealth
Table of Contents
Companies Mentioned
- BD
- Braun
- ICU Medical
- Nipro Medical
- Terumo
- Baxter
- Numedico Technologies
- Codan
- DeRoyal
- Gerresheimer
- Henke Sass Wolf
- HTL Strefa
- Medtronic
- Med XL
- ATS Life Sciences
- Owen Mumford
- PentaFerte
- Schott
- Metier Medical
- CardinalHealth
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 95 |
| Published | December 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 7.97 Billion |
| Forecasted Market Value ( USD | $ 11.76 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 20 |
